Pp405 full presentation on new topical
    3/28/2026

    From the encyclopedia
    PP405 →

    mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this educational post, the primary subjects mentioned are
    💧 PP405 (topical)
    💊 Finasteride (oral)
    💧 Minoxidil (topical)
    the tone is 😀 positive with promising results.

    Other terms

    A new topical treatment, PP405, shows promising results for hair regrowth, potentially outperforming existing treatments like finasteride and minoxidil. However, it may still need to be combined with DHT blockers for optimal results, and its long-term effectiveness remains uncertain.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community 50M Norwood 6. 12 month topical finasteride/minoxidil results

       68 upvotes 8 months ago
      A 50-year-old man used a topical spray with 6% minoxidil and 0.3% finasteride for hair regrowth, experiencing mild side effects but satisfactory results after 12 months. He is considering a hair transplant and shared his progress to show the potential of this treatment.

      community My Hair Loss Protocol - Actually works!!!

       14 upvotes 1 month ago
      A 22-year-old man experienced significant hair regrowth using a combination of biotin supplements, Hims topical finasteride + minoxidil solution, a microneedling pen, 0.5 mg dutasteride, and topical PP405 solution. Despite skepticism about PP405's effectiveness, he claims this regimen worked for him after previous treatments failed.

    Related Research

    6 / 6 results
      Recent Advances in Drug Development for Hair Loss

      research Recent Advances in Drug Development for Hair Loss

      April 2025 in “International Journal of Molecular Sciences”
      This review highlights the limitations of existing hair loss treatments like minoxidil and finasteride and suggests that future therapies may benefit from focusing on antibody and cell-based treatments, which offer targeted and potentially transformative options for managing hair loss disorders.
      New Therapeutics in the Management of Androgenetic Alopecia

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.

      research Emerging pharmacotherapies for Androgenetic Alopecia

      June 2026 in “Expert Opinion on Pharmacotherapy”
      This article reviews emerging therapies for androgenetic alopecia, highlighting advances like androgen-receptor antagonists and improved minoxidil delivery that aim to enhance treatment efficacy and safety.
      Estrogen Functions in Skin and Skin Appendages

      research Oestrogen functions in skin and skin appendages

      68 citations , June 2005 in “Expert Opinion on Therapeutic Targets”
      This review discusses the influence of oestrogens on various skin components and highlights their modulatory roles and receptor pathways, but it reports no new clinical results.